Successful treatment of calcific uremic arteriolopathy with pamidronate
Calcific uremic arteriolopathy is a rare, life-threatening obliterative small vessel vasculopathy, most commonly seen in patients with chronic renal failure. The most prominent feature of this disease is painful lesions on various areas of the skin surface. It has a complex and poorly understood pathogenesis, which limits treatment strategies. Despite all the controversies, bisphosphonates have been successfully applied in some patients. Our paper describes a case of calcific uremic arteriolopathy in a 33-year-old woman undergoing peritoneal dialysis, successfully treated with pamidronate
Saved in:
Main Authors: | Ferreira,Emanuel, Marques,Maria, Pinto,Helena, Bota,Nsecumesso, Belmira,Ana, Carreira,Armando, Campos,Mario |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Portuguesa de Nefrologia
2015
|
Online Access: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692015000100011 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Calcific uraemic arteriolopathy - A mini-review
by: Mendes,Filipa Brito, et al.
Published: (2016) -
Calcific uraemic arteriolopathy (calciphylaxis) in patients on renal replacement therapy
by: Sebastian,S, et al.
Published: (2017) -
Subcapsular liver hematoma as a complication of an atypical hemolytic uremic syndrome
by: Ferreira,Emanuel, et al.
Published: (2015) -
Eculizumab for the treatment of an atypical hemolytic uremic syndrome with mutations in complement factor I and C3
by: Ferreira,Emanuel, et al.
Published: (2016) -
Use of pamidronate for osteoporosis treatment in public health care in Brazil
by: Zanatta,Leila Bianchet, et al.
Published: (2017)